Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹923.80down ₹22.20 (2.35%)BSE ₹924.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹946.00.
30 Oct: open ₹946.00, high ₹951.80, low ₹920.00
52-week range of traded prices to 30 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Next results date: the board meets on 13 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,714 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 35.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,22937.1% delivered
Jubilant Pharmova results
112 filed, newest first. Page 3 of 3.
Jul 2008
4 Jul · Results
Based on the Postal Ballot forms received from shareholders and as per the Scrutinizer's Report dated July 02, 2008, the following special Resolution (as per attachment) have been declared passed with requisite majority. A summary of the votes received on these resolution and the details of the resolutions shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
22 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 53430 lacs for quarter ending on 31-MAR-2008 against Rs. 42960 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5710 lacs for the quarter ending on 31-MAR-2008 against Rs. 6960 lacs for the quarter ending on 31-MAR-2007.22 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 68900 lacs for quarter ending on 31-MAR-2008 against Rs. 46330 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5820 lacs for the quarter ending on 31-MAR-2008 against Rs. 6380 lacs for the quarter ending on 31-MAR-2007.22 Apr · Results
Standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 197670 lacs for year ending on 31-MAR-2008 against Rs. 160970 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 39230 lacs for the year ending on 31-MAR-2008 against Rs. 23150 lacs for the year ending on 31-MAR-2007.22 Apr · Results
Consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 248890 lacs for year ending on 31-MAR-2008 against Rs. 180970 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 40050 lacs for the year ending on 31-MAR-2008 against Rs. 22800 lacs for the year ending on 31-MAR-2007.
Jan 2008
30 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 49450 lacs for quarter ending on 31-DEC-2007 against Rs. 41280 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 8510 lacs for the quarter ending on 31-DEC-2007 against Rs. 6030 lacs for the quarter ending on 31-DEC-2006.30 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 64160 lacs for quarter ending on 31-DEC-2007 against Rs. 46930 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 8940 lacs for the quarter ending on 31-DEC-2007 against Rs. 6370 lacs for the quarter ending on 31-DEC-2006.
Oct 2007
16 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 61830 lacs for quarter ending on 30-SEP-2007 against Rs. 46590 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11000 lacs for the quarter ending on 30-SEP-2007 against Rs. 5440 lacs for the quarter ending on 30-SEP-2006.16 Oct · Results
Standalone Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 94790 lacs for half year ending on 30-SEP-2007 against Rs. 76730 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 25010 lacs for the half year ending on 30-SEP-2007 against Rs. 10160 lacs for the half year ending on 30-SEP-2006.16 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 49300 lacs for quarter ending on 30-SEP-2007 against Rs. 40860 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11170 lacs for the quarter ending on 30-SEP-2007 against Rs. 5420 lacs for the quarter ending on 30-SEP-2006.
Jul 2007
17 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 45490 lacs for quarter ending on 30-JUN-2007 against Rs. 35870 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 13840 lacs for the quarter ending on 30-JUN-2007 against Rs. 4740 lacs for the quarter ending on 30-JUN-2006.17 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 54000 lacs for quarter ending on 30-JUN-2007 against Rs. 41240 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 14290 lacs for the quarter ending on 30-JUN-2007 against Rs. 4610 lacs for the quarter ending on 30-JUN-2006.